Приказ основних података о документу

dc.creatorBrkušanin, Milos
dc.creatorJeftović-Velkova, Irena
dc.creatorJovanović, Vladimir
dc.creatorPerić, Stojan
dc.creatorPešović, Jovan
dc.creatorBrajušković, Goran
dc.creatorStević, Zorica
dc.creatorSavić-Pavićević, Dušanka
dc.date.accessioned2019-08-29T12:16:20Z
dc.date.available2019-08-29T12:16:20Z
dc.date.issued2018
dc.identifier.urihttp://www.doiserbia.nb.rs/Article.aspx?ID=0370-81791800069B
dc.identifier.urihttps://radar.ibiss.bg.ac.rs/handle/123456789/3452
dc.description.abstractIntroduction/Objective. Amyotrophic lateral sclerosis (ALS) is a devastating motor neuron disease. The majority of cases are apparently sporadic ALS (SALS) with variants in susceptibility genes or sometimes in high-risk ALS genes. Two ALS susceptibility genes are SMN1, whose functional loss causes spinal muscular atrophy (SMA), and a nearly identical SMN2 gene, which modulates SMA severity. In this study we examined the association of copy number variations (CNVs) of SMN1 and SMN2 genes and two additional genes, SERF1 and NAIP, residing in the same genomic region (i.e. 5q13.2 segmental duplication), with SALS in patients from Serbia. Methods. Multiplex ligation-dependent probe amplification was used to determine CNVs of each gene in a clinically well-characterised group of 153 Serbian SALS patients and 153 controls. Results. Individual association between SMN1, SMN2, SERF1 or NAIP CNVs and SALS susceptibility or survival was not found. Survival curves based on the multivariable Cox regression analysis showed that three SMN1 copies, lower ALS Functional Rating Scale Revised (ALSFRS-R) score at the time of diagnosis, faster decline of the ALSFRS-R score over time, and shorter diagnostic delay result in shorter survival of Serbian SALS patients. Conclusion. Clinical variables might be complemented with the SMN1 copy number to improve prediction of survival in Serbian SALS patients.en
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173016/RS//
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.sourceSrpski arhiv za celokupno lekarstvo
dc.subjectSurvival motor neuron
dc.subjectAmyotrophic lateral sclerosis
dc.subjectH4F5
dc.subjectNAIP
dc.subjectSMN1
dc.titleSMN1 copy number as a modifying factor of survival in Serbian patients with sporadic amyotrophic lateral sclerosisen
dc.typearticleen
dc.rights.licenseBY-NC
dcterms.abstractПешовић, Јован; Брајушковић, Горан; Стевић, Зорица; Савић-Павићевић, Душанка; Бркушанин, Милос; Јефтовић-Велкова, Ирена; Јовановић, Владимир; Перић, Стојан;
dc.rights.holder© 2018, Serbia Medical Society.
dc.citation.issue11-12
dc.citation.volume146
dc.identifier.doi10.2298/SARH180801069B
dc.identifier.scopus2-s2.0-85070026309
dc.identifier.wos000456102100005
dc.citation.apaBrkušanin, M., Jeftović-Velkova, I., Jovanović, V., Perić, S., Pešović, J., Brajušković, G., et al. (2018). SMN1 copy number as a modifying factor of survival in Serbian patients with sporadic amyotrophic lateral sclerosis. Srpski Arhiv Za Celokupno Lekarstvo, 146(11–12), 646–652.
dc.citation.vancouverBrkušanin M, Jeftović-Velkova I, Jovanović V, Perić S, Pešović J, Brajušković G, Stević Z, Savić-Pavićević D. SMN1 copy number as a modifying factor of survival in Serbian patients with sporadic amyotrophic lateral sclerosis. Srp Arh Celok Lek. 2018;146(11–12):646–52.
dc.citation.spage646
dc.citation.epage652
dc.type.versionpublishedVersion
dc.identifier.fulltexthttps://radar.ibiss.bg.ac.rs/bitstream/id/5369/bitstream_5369.pdf
dc.citation.rankM23


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу